Literature DB >> 7565737

Evidence for a G2 checkpoint in p53-independent apoptosis induction by X-irradiation.

Z Han1, D Chatterjee, D M He, J Early, P Pantazis, J H Wyche, E A Hendrickson.   

Abstract

The p53 tumor suppressor gene is thought to be required for the induction of programmed cell death (apoptosis) initiated by DNA damage. We show here, however, that the human promyelocytic leukemia cell line HL-60, which is known to be deficient in p53 because of large deletions in the p53 gene, can be induced to undergo apoptosis following X-irradiation. We demonstrate that the decision to undergo apoptosis in this cell line appears to be made at a G2 checkpoint. In addition, we characterize an HL-60 variant, HCW-2, which is radioresistant. HCW-2 cells display DNA damage induction and repair capabilities identical to those of the parental HL-60 cell line. Thus, the difference between the two cell lines appears to be that X-irradiation induces apoptosis in HL-60, but not in HCW-2, cells. Paradoxically, HCW-2 cells display high levels of expression of bax, which enhances apoptosis, and no longer express bcl-2, which blocks apoptosis. HCW-2 cells' resistance to apoptosis may be due to the acquisition of expression of bcl-XL, a bcl-2-related inhibitor of apoptosis. In summary, apoptosis can be induced in X-irradiated HL-60 cells by a p53-independent mechanism at a G2 checkpoint, despite the presence of endogenous bcl-2. The resistance shown by HCW-2 cells suggests that bcl-XL can block this process.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7565737      PMCID: PMC230836          DOI: 10.1128/MCB.15.11.5849

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  64 in total

1.  Asymmetric field inversion gel electrophoresis: a new method for detecting DNA double-strand breaks in mammalian cells.

Authors:  T D Stamato; N Denko
Journal:  Radiat Res       Date:  1990-02       Impact factor: 2.841

Review 2.  DNA damage produced by ionizing radiation in mammalian cells: identities, mechanisms of formation, and reparability.

Authors:  J F Ward
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1988

3.  Rapid and quantitative preparation of cytoplasmic RNA from small numbers of cells.

Authors:  N M Gough
Journal:  Anal Biochem       Date:  1988-08-15       Impact factor: 3.365

Review 4.  Survival of cells in mammalian tissues after low doses of irradiation: a short review.

Authors:  J H Hendry
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1988-01

5.  Increased UV-induced SCEs but normal repair of DNA damage in p53-deficient mouse cells.

Authors:  K Ishizaki; Y Ejima; T Matsunaga; R Hara; A Sakamoto; M Ikenaga; Y Ikawa; S Aizawa
Journal:  Int J Cancer       Date:  1994-07-15       Impact factor: 7.396

6.  Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation.

Authors:  A H Wyllie
Journal:  Nature       Date:  1980-04-10       Impact factor: 49.962

7.  Involvement of double-strand chromosomal breaks for mating-type switching in Saccharomyces cerevisiae.

Authors:  A J Klar; J N Strathern; J A Abraham
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1984

8.  The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae.

Authors:  T A Weinert; L H Hartwell
Journal:  Science       Date:  1988-07-15       Impact factor: 47.728

9.  Evidence for a general relationship between the induced level of DNA double-strand breakage and cell-killing after X-irradiation of mammalian cells.

Authors:  I R Radford
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1986-04

10.  Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells.

Authors:  D Wolf; V Rotter
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

View more
  16 in total

Review 1.  Soft tissue sarcomas and p53 mutations.

Authors:  H Taubert; A Meye; P Würl
Journal:  Mol Med       Date:  1998-06       Impact factor: 6.354

2.  Apoptosis: A Current Molecular Analysis.

Authors:  Dean G Tang; Arthur T Porter
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

3.  Cleavage of the Bloom's syndrome gene product during apoptosis by caspase-3 results in an impaired interaction with topoisomerase IIIalpha.

Authors:  R Freire; F d'Adda Di Fagagna; L Wu; G Pedrazzi; I Stagljar; I D Hickson; S P Jackson
Journal:  Nucleic Acids Res       Date:  2001-08-01       Impact factor: 16.971

4.  Differentiation of human malignant melanoma cells that escape apoptosis after treatment with 9-nitrocamptothecin in vitro.

Authors:  P Pantazis; D Chatterjee; Z Han; J Wyche
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

5.  Cleavage and inactivation of ATM during apoptosis.

Authors:  G C Smith; F d'Adda di Fagagna; N D Lakin; S P Jackson
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

6.  Evidence for DNA-PK-dependent and -independent DNA double-strand break repair pathways in mammalian cells as a function of the cell cycle.

Authors:  S E Lee; R A Mitchell; A Cheng; E A Hendrickson
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

7.  Epstein-Barr virus suppresses a G(2)/M checkpoint activated by genotoxins.

Authors:  M Wade; M J Allday
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

8.  KARP-1: a novel leucine zipper protein expressed from the Ku86 autoantigen locus is implicated in the control of DNA-dependent protein kinase activity.

Authors:  K Myung; D M He; S E Lee; E A Hendrickson
Journal:  EMBO J       Date:  1997-06-02       Impact factor: 11.598

9.  Soluplus--solubilized citrated camptothecin--a potential drug delivery strategy in colon cancer.

Authors:  Naveen K Thakral; Alok R Ray; Daniel Bar-Shalom; André Huss Eriksson; Dipak K Majumdar
Journal:  AAPS PharmSciTech       Date:  2011-11-22       Impact factor: 3.246

10.  [Apoptosis and tumor regression in locally advanced non-small cell lung cancer with neoadjuvant therapy].

Authors:  K Junker; K-M Müller; U Bosse; F Klinke; A Heinecke; M Thomas
Journal:  Pathologe       Date:  2003-03-13       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.